FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1887203709> ?p ?o ?g. }

• W1887203709 endingPage "1549" @default.
• W1887203709 startingPage "1543" @default.
• W1887203709 abstract "Background Mastectomy and breast reconstruction are essential parts of the treatment of breast cancer. Acellular dermal matrices (ADMs) have been used for the reconstruction of the lower pole due to many advantages; however, its cost is seen as a major drawback in this era of concern for the allocation of health-care funds. Recently, polyglactin 910 (Vicryl; Ethicon, Somerville, NJ, USA) mesh has been published as an alternative. We assessed the published literature, in particular investigating for studies that compare Vicryl mesh with ADM. Methods We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. Searched databases included Medline/PubMed, Cochrane Reviews, Embase, Web of Science, ClinicalTrials, and SCOPUS. Search criteria were as follows: (1) reporting of clinical data using Vicryl mesh in breast reconstruction, (2) reporting of original data, and (3) outcome of interest reported. Results We retrieved 290 de-duplicated articles. After title and abstract screening, we dismissed 258 articles, and thus full text was reviewed for 32 articles; only three retrospective articles met inclusion criteria. The total population included 112 patients and 156 breasts. The reported incidence of complications was as follows: infection 2.6% (confidence interval (CI): 0.7–6.6%), reconstruction failure 3.2% (CI: 1.0–7%), and seroma 1.3% (CI: 0.2–4.6%). A seven- to 12-fold cost difference was reported. Follow-up length ranged from 1.2 to 3.6 years. No studies directly compared Vicryl mesh with ADM. Conclusions Although the evidence is limited, polyglactin 910 (Vicryl) mesh for immediate breast reconstruction appears to be a potentially safe, effective, and less expensive alternative to ADM. Prospective studies are needed to further compare mesh with ADM. Mastectomy and breast reconstruction are essential parts of the treatment of breast cancer. Acellular dermal matrices (ADMs) have been used for the reconstruction of the lower pole due to many advantages; however, its cost is seen as a major drawback in this era of concern for the allocation of health-care funds. Recently, polyglactin 910 (Vicryl; Ethicon, Somerville, NJ, USA) mesh has been published as an alternative. We assessed the published literature, in particular investigating for studies that compare Vicryl mesh with ADM. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. Searched databases included Medline/PubMed, Cochrane Reviews, Embase, Web of Science, ClinicalTrials, and SCOPUS. Search criteria were as follows: (1) reporting of clinical data using Vicryl mesh in breast reconstruction, (2) reporting of original data, and (3) outcome of interest reported. We retrieved 290 de-duplicated articles. After title and abstract screening, we dismissed 258 articles, and thus full text was reviewed for 32 articles; only three retrospective articles met inclusion criteria. The total population included 112 patients and 156 breasts. The reported incidence of complications was as follows: infection 2.6% (confidence interval (CI): 0.7–6.6%), reconstruction failure 3.2% (CI: 1.0–7%), and seroma 1.3% (CI: 0.2–4.6%). A seven- to 12-fold cost difference was reported. Follow-up length ranged from 1.2 to 3.6 years. No studies directly compared Vicryl mesh with ADM. Although the evidence is limited, polyglactin 910 (Vicryl) mesh for immediate breast reconstruction appears to be a potentially safe, effective, and less expensive alternative to ADM. Prospective studies are needed to further compare mesh with ADM." @default.
• W1887203709 created "2016-06-24" @default.
• W1887203709 creator A5008052261 @default.
• W1887203709 creator A5019784398 @default.
• W1887203709 creator A5022360698 @default.
• W1887203709 creator A5031196715 @default.
• W1887203709 creator A5039272874 @default.
• W1887203709 creator A5082757983 @default.
• W1887203709 date "2015-11-01" @default.
• W1887203709 modified "2023-09-27" @default.
• W1887203709 title "Low incidence of complications using polyglactin 910 (Vicryl) mesh in breast reconstruction: A systematic review" @default.
• W1887203709 cites W1972062827 @default.
• W1887203709 cites W1975879668 @default.
• W1887203709 cites W1980528021 @default.
• W1887203709 cites W1982980840 @default.
• W1887203709 cites W1983737271 @default.
• W1887203709 cites W1995123353 @default.
• W1887203709 cites W1999451878 @default.
• W1887203709 cites W1999753934 @default.
• W1887203709 cites W2007174544 @default.
• W1887203709 cites W2017044005 @default.
• W1887203709 cites W2024290914 @default.
• W1887203709 cites W2025417415 @default.
• W1887203709 cites W2029587353 @default.
• W1887203709 cites W2030560722 @default.
• W1887203709 cites W2030993903 @default.
• W1887203709 cites W2034851926 @default.
• W1887203709 cites W2036196525 @default.
• W1887203709 cites W2038192396 @default.
• W1887203709 cites W2038258670 @default.
• W1887203709 cites W2053865370 @default.
• W1887203709 cites W2074261473 @default.
• W1887203709 cites W2079713398 @default.
• W1887203709 cites W2092397205 @default.
• W1887203709 cites W2097165363 @default.
• W1887203709 cites W2109812697 @default.
• W1887203709 cites W2134833483 @default.
• W1887203709 cites W2146232565 @default.
• W1887203709 cites W2149553178 @default.
• W1887203709 cites W2172264039 @default.
• W1887203709 cites W2320857131 @default.
• W1887203709 cites W2330615419 @default.
• W1887203709 cites W2333385158 @default.
• W1887203709 cites W4248912471 @default.
• W1887203709 doi "https://doi.org/10.1016/j.bjps.2015.06.018" @default.
• W1887203709 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26275493" @default.
• W1887203709 hasPublicationYear "2015" @default.
• W1887203709 type Work @default.
• W1887203709 sameAs 1887203709 @default.
• W1887203709 citedByCount "26" @default.
• W1887203709 countsByYear W18872037092016 @default.
• W1887203709 countsByYear W18872037092017 @default.
• W1887203709 countsByYear W18872037092018 @default.
• W1887203709 countsByYear W18872037092019 @default.
• W1887203709 countsByYear W18872037092020 @default.
• W1887203709 countsByYear W18872037092021 @default.
• W1887203709 countsByYear W18872037092022 @default.
• W1887203709 countsByYear W18872037092023 @default.
• W1887203709 crossrefType "journal-article" @default.
• W1887203709 hasAuthorship W1887203709A5008052261 @default.
• W1887203709 hasAuthorship W1887203709A5019784398 @default.
• W1887203709 hasAuthorship W1887203709A5022360698 @default.
• W1887203709 hasAuthorship W1887203709A5031196715 @default.
• W1887203709 hasAuthorship W1887203709A5039272874 @default.
• W1887203709 hasAuthorship W1887203709A5082757983 @default.
• W1887203709 hasConcept C120665830 @default.
• W1887203709 hasConcept C121332964 @default.
• W1887203709 hasConcept C121608353 @default.
• W1887203709 hasConcept C126322002 @default.
• W1887203709 hasConcept C141071460 @default.
• W1887203709 hasConcept C17744445 @default.
• W1887203709 hasConcept C189708586 @default.
• W1887203709 hasConcept C199539241 @default.
• W1887203709 hasConcept C2776881634 @default.
• W1887203709 hasConcept C2777327002 @default.
• W1887203709 hasConcept C2777757722 @default.
• W1887203709 hasConcept C2779409168 @default.
• W1887203709 hasConcept C2779473830 @default.
• W1887203709 hasConcept C2781001896 @default.
• W1887203709 hasConcept C2781037480 @default.
• W1887203709 hasConcept C44249647 @default.
• W1887203709 hasConcept C530470458 @default.
• W1887203709 hasConcept C61511704 @default.
• W1887203709 hasConcept C71924100 @default.
• W1887203709 hasConcept C81182388 @default.
• W1887203709 hasConceptScore W1887203709C120665830 @default.
• W1887203709 hasConceptScore W1887203709C121332964 @default.
• W1887203709 hasConceptScore W1887203709C121608353 @default.
• W1887203709 hasConceptScore W1887203709C126322002 @default.
• W1887203709 hasConceptScore W1887203709C141071460 @default.
• W1887203709 hasConceptScore W1887203709C17744445 @default.
• W1887203709 hasConceptScore W1887203709C189708586 @default.
• W1887203709 hasConceptScore W1887203709C199539241 @default.
• W1887203709 hasConceptScore W1887203709C2776881634 @default.
• W1887203709 hasConceptScore W1887203709C2777327002 @default.
• W1887203709 hasConceptScore W1887203709C2777757722 @default.
• W1887203709 hasConceptScore W1887203709C2779409168 @default.
• W1887203709 hasConceptScore W1887203709C2779473830 @default.

• next